Physician and Patient Safety Act

1) What happened: HR3413 was introduced in the House on May 14, 2025 by Rep. Ruiz (D-CA) and referred to the House Committee on Energy and Commerce. The bill has 6 cosponsors and an identical companion bill (S1767) in the Senate. As of today (April 30, 2026), the bill remains in committee with no further action — it is stalled in early stage. 2) The money trail: There is zero funding authorization or appropriation in this bill. It is a pure regulatory mandate — it instructs HHS to issue regulations requiring hospitals to provide fair hearings and appellate review before terminating or restricting physician staff privileges. No federal dollars flow. No tax credits, grants, or procurement programs are created. 3) Structural winners and losers: This is not a market-moving bill. Hospitals ($HCA, $UHS) face modest operational friction from additional administrative and legal procedures, but the cost is immaterial relative to their revenue bases (HCA's 2025 revenue ~$70B; UHS ~$16B). Physician staffing companies ($AMN, $CHG Healthcare private) could see minor benefits if the due-process protections make hospital employment less desirable, but this is speculative and not grounded in bill text. No clear winners. 4) Timeline: The bill requires HHS to issue final regulations within 18 months of enactment. However, the bill has not advanced out of committee in nearly a year. Without substantial committee leadership sponsorship or a broader legislative vehicle, passage in this Congress is unlikely.